Relapsed or Refractory Lymphoid Malignancies
2 clinical trials · Condition
◉ Watch Relapsed or Refractory Lymphoid Malignancies
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies (NCT01703572) | OncoMed Pharmaceuticals, Inc. | 2012-10-01 |
Track Relapsed or Refractory Lymphoid Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.